COVID-19 infection has been associated with the development of several autoimmune diseases.1 In addition, anti-citrullinated protein antibodies (ACPA) and rheumatoid arthritis (RA) flaring after SARS-CoV-2 infection have also been described.2–4. This evidence concerns the gene PRTN3 and rheumatoid arthritis.